MetaCap

Fortress Biotech (FBIO) Stock Chart

NASDAQ: FBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.90+0.13 (+7.34%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

FBIO technical summary

FBIO is trading 7.6% below its 50-day simple moving average of $2.06 and 29.1% below its 200-day average of $2.68. The 50-day average is below the 200-day average, a configuration technical analysts associate with a longer-term downtrend. The 14-day Relative Strength Index (RSI) is 47.9, within the neutral 30 to 70 band.

Over the past year, the stock ranged from $1.64 (Nov 17, 2026) to $4.53 (Jan 9, 2026); the current price sits 9% of the way from the low to the high. Annualized 30-day volatility is 69.7%. Based on the last session's high, low and close, the classic pivot point is $1.91, with first resistance at $1.98 and first support at $1.83.

These indicators describe past price behavior for Fortress Biotech; they are not predictions.

Summary generated from market data by MetaCap's automated system. Methodology

Technical indicators

Beta
—
1Y high
4.53 (Jan 9)
1Y low
1.64 (Nov 17)
Last close
1.90

FBIO price performance

1 week

+1.06%

1 month

-2.06%

3 months

-33.80%

6 months

-30.66%

Year to date

-48.09%

1 year

-26.64%

3 years

-13.64%

5 years

-95.52%

FBIO price return, excluding dividends.

Moving averages

Simple and exponential moving averages
PeriodSimple (SMA)Exponential (EMA)
5-day1.82Price above1.85Price above
10-day1.89Price above1.87Price above
20-day1.90Price below1.91Price below
50-day2.06Price below2.09Price below
100-day2.53Price below2.34Price below
200-day2.68Price below2.62Price below

Moving averages are computed from daily closing prices over the past year. What is a moving average?

Pivot points

Classic pivot points
LevelPrice
Resistance 3 (R3)2.13
Resistance 2 (R2)2.06
Resistance 1 (R1)1.98
Pivot point1.91
Support 1 (S1)1.83
Support 2 (S2)1.76
Support 3 (S3)1.68

Classic floor-trader pivots from the last session's high, low and close. How pivot points work

Learn technical analysis